Details.
A virtual or in-person consultation with a licensed provider to review medical history, lifestyle, and goals, assess BMI, and determine eligibility for Semaglutide or alternative therapies. The provider discusses whether Semaglutide or a similar GLP-1 therapy such as Tirzepatide is appropriate, provides usage instructions and lifestyle recommendations, and creates a plan for regular follow-ups. Candidates may include people with a BMI of 30 or higher, or a BMI of 27 or higher with a related condition such as high blood pressure, elevated cholesterol, or prediabetes.
